An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection

INTRODUCTION: A Proteosome-adjuvanted trivalent inactivated influenza vaccine (P-TIV) administered intra-nasally was shown to be safe, well tolerated and immunogenic in both systemic and mucosal compartments, and effective at preventing illness associated with evidence of influenza infection. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambkin-Williams, Rob, Gelder, Colin, Broughton, Richard, Mallett, Corey P., Gilbert, Anthony S., Mann, Alex, He, David, Oxford, John S., Burt, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179046/
https://www.ncbi.nlm.nih.gov/pubmed/28005959
http://dx.doi.org/10.1371/journal.pone.0163089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179046/
https://www.ncbi.nlm.nih.gov/pubmed/28005959
http://dx.doi.org/10.1371/journal.pone.0163089

Ejemplares similares